171 results
8-K
EX-99.1
LAB
Standard BioTools Inc.
5 Sep 24
Standard BioTools 1 Unleashing Tools to Accelerate Breakthroughs in Human Health INVESTOR PRESENTATION September 2024
4:07pm
PROTEOMICS SPATIAL PROTEOMICS Our Solutions Cover the Four Sources of Critical Biomarker Information GENOMICS/ MULTIOMICS Our M&A Strategy has delivered
8-K
EX-99.1
LAB
Standard BioTools Inc.
31 Jul 24
Standard BioTools Announces Senior Leadership Changes
4:20pm
on executing our growth strategy.”
Egholm concluded, “I want to thank Jeff for his many contributions, including helping us build a strong finance function
8-K
EX-99.1
LAB
Standard BioTools Inc.
31 Jul 24
Standard BioTools Reports Second Quarter 2024 Financial Results
4:12pm
System is more fully deployed.”
“It is early days for the Standard BioTools strategy and vision as we bring improved operational discipline
SD
EX-1.01
37slq92h1 t1
29 May 24
Conflict minerals disclosure
4:34pm
DEFC14A
ik7w l1eotn4i
21 May 24
Proxy in contested solicitation
5:15pm
PRER14A
fcnmc 2bv2c
20 May 24
Preliminary revised proxy
6:03am
PREC14A
m37ux25vhk0q
10 May 24
Preliminary proxy with contested solicitation
5:16pm
8-K
EX-99.1
49ol5ho5
8 May 24
Standard BioTools Reports First Quarter 2024 Financial Results
4:31pm
8-K
EX-99.1
4apbv5 fjkh
25 Apr 24
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
8:06am
8-K
EX-99.1
236hciy iba2s
18 Mar 24
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
9:14am
8-K
EX-99.1
t9327l xd2znjg29z3v
28 Feb 24
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K/A
EX-99.1
erjyl
19 Jan 24
Financial Statements and Exhibits
4:33pm
8-K/A
EX-99.2
8fopfi47rl3l23er
19 Jan 24
Financial Statements and Exhibits
4:33pm
8-K
EX-99.2
s1lhu6gh
8 Jan 24
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
8:39am
8-K
EX-99.2
826 98y8u
5 Jan 24
Standard BioTools Stockholders Approve Merger with SomaLogic
8:53am